Administrative Core (A) is the innovative and synergistic engine driving the Penn CFAR, a collaboration ofthe University of Pennsylvania and its Perelman School of Medicine, Children's Hospital of Philadelphia, and Wistar Institute. Core A establishes and oversees Shared Resource Cores, educational activities, a Developmental Core, mentoring activities of junior investigators, and initiatives that build strong ties to the campus and community. Core A will continue to be led by Director James Hoxie, MD and Co- Director Ronald Collman, MD. Core A works closely with a governing Executive Committee, Internal Advisory Board, External Advisory Committee, and Community Advisory Board. In addition to the Cores, Core A oversees the CFAR's 4 Research Areas (Virology/Pathogenesis, Clinical/Therapeutics, Immunology vaccine, Behavioral &Social Sciences) and the new Scientific Working Groups (SWGs) (Viral Hepatitis &HIV Co-Infection, HIV Eradication &Functional Control, AIDS &Addiction). Core A provides the management and scientific direction for the CFAR and establishes the necessary linkages among participants. Core A's primary responsibilities are to 1) facilitate communication among CFAR members;2) lead a robust and transparent strategic planning process: 3) ensure that opportunities in emerging scientific areas and technologies in HIV/AIDS research are recognized and pursued: 4) ensure that Core facilities serve the research needs of members and comply with the policies by which they were established;5) enforce sound fiscal management and accountability for Core activities and Developmental funds;6) create multidisciplinary and vibrant educational programs for faculty and students;7) provide resources, organizational capacity, and scientific direction to CFAR SWGs;8) pursue strong outreach programs that address the needs of domestic and international populations most affected by the HIV epidemic;9) foster collaborations throughout the national CFAR network: and 10) promote diversity and inclusion in all CFAR activities. Core A is deeply committed to initiatives that build strong ties for the CFAR to the campus and the Philadelphia community, the CFAR network, and to international programs of Core I and inter-CFAR collaborations.
For 14 years, Core A has led the Penn CFAR in creating an interactive and collaborative HIV/AIDS research climate, vibrant educational activities, and innovative community outreach programs. Core A conducts, coordinates, and monitors CFAR activities to build infrastructure that fosters interdisciplinary and translational HIV/AIDS research and provides scientific leadership. It has also played the leadership role in the strategic planning process that has defined the exciting action plan for the next funding period.
|Frye, Margaret; Chae, Sophia (2017) Physical attractiveness and women's HIV risk in rural Malawi. Demogr Res 37:251-294|
|Reid, Michael J A; Steenhoff, Andrew P; Mannathoko, Naledi et al. (2017) Staphylococcus aureus nasal colonization among HIV-infected adults in Botswana: prevalence and risk factors. AIDS Care 29:961-965|
|Koenig, H C; Mounzer, K; Daughtridge, G W et al. (2017) Urine assay for tenofovir to monitor adherence in real time to tenofovir disoproxil fumarate/emtricitabine as pre-exposure prophylaxis. HIV Med 18:412-418|
|Kelly, Matthew S; Surette, Michael G; Smieja, Marek et al. (2017) The Nasopharyngeal Microbiota of Children With Respiratory Infections in Botswana. Pediatr Infect Dis J 36:e211-e218|
|Kim, Dorothy; Hofstaedter, Casey E; Zhao, Chunyu et al. (2017) Optimizing methods and dodging pitfalls in microbiome research. Microbiome 5:52|
|Pardi, Norbert; Secreto, Anthony J; Shan, Xiaochuan et al. (2017) Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge. Nat Commun 8:14630|
|Wood, Sarah M; Lee, Susan; Barg, Frances K et al. (2017) Young Transgender Women's Attitudes Toward HIV Pre-exposure Prophylaxis. J Adolesc Health 60:549-555|
|Li, Shuying S; Kochar, Nidhi K; Elizaga, Marnie et al. (2017) DNA Priming Increases Frequency of T-Cell Responses to a Vesicular Stomatitis Virus HIV Vaccine with Specific Enhancement of CD8+ T-Cell Responses by Interleukin-12 Plasmid DNA. Clin Vaccine Immunol 24:|
|Kohler, Iliana V; Payne, Collin F; Bandawe, Chiwoza et al. (2017) The Demography of Mental Health Among Mature Adults in a Low-Income, High-HIV-Prevalence Context. Demography 54:1529-1558|
|Clarke, Erik L; Sundararaman, Sesh A; Seifert, Stephanie N et al. (2017) swga: a primer design toolkit for selective whole genome amplification. Bioinformatics 33:2071-2077|
Showing the most recent 10 out of 605 publications